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Summary 
CD45  expression is essential for immunoglobulin  (Ig)-mediated B  cell activation.  Treatments 
with either anti-Ig or anti-CD45 suggest that CD45 may facilitate early signaling events such as 
calcium mobilization,  and phosphoinositide  hydrolyis as  well  as  later  events  leading to tran- 
scription of genes such as c-myc. To examine the role of CD45 more extensively, CD45-defi- 
cient mice were generated by disruption of exon 6. Although normal numbers of B cells were 
found in peripheral lymphoid tissues,  CD45-deficient cells failed to proliferate upon IgM cross- 
linking. In the present study, we demonstrate that the fraction of high buoyant density B cells is 
reduced while low buoyant density cells  are increased. Moreover, there is a significant decline 
in the number of splenic B cells of the mature lgD hi, IgM  I~ phenotype. Although both the basal 
and  anti-Ig-induced levels  of phosphorylation  of Ig-0t  and  phospholipase  C',/2  are  indistin- 
guishable from that observed in CD45 + control B  cells,  a major distinction was found in Ca  2+ 
mobilization. While anti-Ig-induced mobilization of intracellular Ca  2+  stores was normal, in- 
flux from extracellular sources was abrogated. This finding reveals a novel pathway of regulat- 
ing B  cell responses mediated by CD45. 
E 
vidence from a variety of sources clearly demonstrates 
that the  expression  of CD45  is essential  for activation 
of B  lymphocytes after cross-linking of the B  cell receptor 
(BCR)  (1-6). In vitro activation studies using primary cells 
treated with either anti-Ig or anti-CD45 suggest that CD45 
facilitates  early signaling  events  such  as  calcium mobiliza- 
tion  (6),  and  phosphoinositide  hydrolyis  as  well  as  later 
events leading to  transcription  of genes such as c-myc (7). 
Cell  lines  have  also  been  used  to  examine  the  role  of 
CD45. In some cases conflicting results have emerged from 
such  studies.  For  example,  it  was  demonstrated  that  the 
plasmacytoma  J558LIxm3,  which  lacks  CD45,  failed  to 
mobilize Ca  2+ after BCR cross-linking. This effect was re- 
stored in J558LF~m3 cells by transfection with a eDNA en- 
coding  CD45  (1).  In  contrast,  CD45-  variants  of  the 
CD45 +  immature  cell  line  WEHI231,  had  a  slightly  de- 
layed  but  increased  and  prolonged  Ca  2+  response  upon 
BCR  cross-linking  (8).  Whether  this  discrepancy  accu- 
rately  reflects  the  different  maturation  states  of these  cell 
lines,  or  is  due  to  abnormalities  peculiar  to  transformed 
cells,  remains to be determined. 
To examine the role of CD45 more extensively, CD45- 
deficient mice were generated by disruption of exon 6  (9). 
Mice homozygous for the  CD45  exon 6  mutation  lacked 
CD45  expression  on B  cells  and  on  the  majority  of thy- 
mocytes and peripheral T  cells.  A  block in T  cell develop- 
ment occurred at the transition from immature CD4+CD8 + 
double-positive  to  mature  single-positive  thymocytes  re- 
sulting in a significant reduction in peripheral  T  cells.  Re- 
sidual peripheral  T  cells  exhibited  impaired anti-CD3  and 
anti-TCR signaling. In contrast to the paucity of peripheral 
T  cells,  approximately  normal  numbers  of B  cells  were 
found in peripheral  lymphoid tissues.  Furthermore,  the  B 
cells  detected  were  responsive  to  the  B  cell  mitogen,  li- 
popolysaccharide,  and  serum  levels  of both  IgM and  IgG 
were near normal.  However,  thymidine  incorporation as- 
says revealed that CD45-deficient cells  failed to proliferate 
after cross-linking with IgM-specific antibodies.  These re- 
sults confirmed that CD45 plays a critical role in B  cell ac- 
tivation as previously demonstrated  in other  experimental 
systems. 
Materials and Methods 
Mice.  Mice used were CD45 exon 6 -/-,  originally derived 
by Kenji Kishihara,  after fifth backcross  with C57BL/6. Control 
mice were either age-matched C57BL/6 or CD45 exon 6 +/+ 
mice of the fifth backcross to C57BL/6. 
B Cell Purification.  Bone  marrow  was  prepared  by  flushing 
tibias and femurs with a 26-gauge syringe. Single cell suspensions 
of splenic B cells were prepared by mincing over a metal screen 
with a syringe plunger followed by a 5-rain incubation on ice to 
remove  large  aggregates.  Erythrocytes  were  lysed  with  ACK 
(0.155 M ammonium chloride,  0.1 mM disodium EDTA, 0.01 M 
potassium  bicarbonate,  pH 7.3)  for 5 rain on ice.  T  cells were 
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(HO13.4)  antibody supernatants  (1:20  dilution) together  with 
low tox guinea pig complement (1/12 dilution) (Cedarlane Labo- 
ratories Ltd.,  Hornby, Canada)  for  1 h  at 37~  The remaining 
cells were separated on a Percofl gradient (Sigma Chemical Co., 
St. Louis, MO) as described (10). 
~H]Thymidine Incorporation Assay.  Splenic B  cells were  placed 
in flat-bottomed 96-well plates (Costar  Corp., Cambridge, MA) 
in OPTI-MEM (GIBCO BR.L, Gaithersburg, MD) medium sup- 
plemented with 2.4 g/liter NaHCO3, 5 mg/ml streptomycin, 5 ￿ 
103 U/liter penicillin, 5 ￿  10  s M 2-mercaptoethanot,  0.5% FCS 
(GIBCO BRL,  Gaithersburg,  MD)  at  10  s cells/well with either 
medium alone, LPS (20 b~g/ml), B76 (rat IgG1 anti-mouse Igb~; 
30 p~g/ml), or goat  anti-mouse Igb~ (30 p~g/ml; Jackson Immu- 
noresearch Laboratories,  West Grove, PA) at various concentra- 
tions. B cells were harvested  at various intervals after a 6-h pulse 
with 1 p~Ci of [3H]thymidine per well. 
Flow Cytometry.  Cells (1-5  ￿  10S/sample) were washed  and 
exposed to appropriate  antibodies for 15 min on ice. Before anal- 
ysis, cells were  fixed  in 1% paraformaldehyde.  104  cells/sample 
were analyzed on a FACScan  |  flow cytometer (Becton Dickin- 
son and Co., San Jose,  CA) using Lysys II software. The follow- 
ing mAbs were used: RA3-6B2 (B220, PE labeled; Pharmingen, 
San Diego, CA); 33-60 (anti-slgM; FITC and biotin labeled; the 
hybridoma, 33-60  [11]); anti-slgD (PE  labeled;  Southern Bio- 
technology  Associates,  Birmingham,  AL);  anti-CD23  (PE  la- 
beled; Pharmingen) M5-114 (anti-H-26a-FITC  labeled). Biotiny- 
lated antibodies were visualized with streptavidin-PerCP (Becton 
Dickinson) or streptavidin-Quantum  red conjugate  (Sigma Chem- 
ical Co.). 
BM Reconstitulion Experiments.  Donor bone marrow was panned 
on plates coated with anti-IgM, 33-60, for 1 h at 4~  to remove 
mature  B  cells. Nonadherent cells were  harvested  and  resus- 
pended in PBS at 5  ￿  106/ml.  Recipients were irradiated  with 
900 rads and subsequently reconstituted with 2 ￿  106 bone mar- 
row cells via tail vein injection. Mice were analyzed 9-11 wk af- 
ter reconstitution by flow cytometric analysis of spleen and bone 
marrow. 
Immunoprecipitation and Western Blotting.  MB-1  immunopre- 
cipitation was  performed  as  described  (12). A  1:50  dilution of 
rabbit antisera against mb-1 was used. Samples were boiled 5 rain 
before  separation  of proteins on  10% polyacrylamide  gels, fol- 
lowed by transfer to nitrocellulose by electroblotting for 2 h at 50 V. 
The membrane was blocked with wash buffer (20 mM Tris, 0.5 M 
NaC1,  0.1%  Tween, pH  7.6)  containing 3%  gelatin for  1 h  at 
room  temperature.  Antibody incubations were  done  in  wash 
buffer containing 1% gelatin for  1 h  at  room temperature, fol- 
lowed by 5  ￿  5  min washes.  Antiphosphotyrosine blots  were 
performed using a 1/1,000 dilution of antiphosphotyrosine mAb 
4G10  (Upstate  Biotechnology Inc., Lake  Placid,  NY)  followed 
by a 1/2,000 dilution of horseradish  peroxidase  (HP,  P)-coupled 
goat anti-mouse IgG (Sigma Chemical Co.). Bands were visual- 
ized  by  enhanced chemiluminescence detection system  (NEN 
Dupont, Boston, MA). Blots were stripped  by incubation for  15 
min in  10  mM  Tris-C1  pH  2.3;  150  mM  NaC1, followed by 
washing five times in the same buffer at pH 8. For anti-phospho- 
lipase  C  (PLC)y2  immunoprecipitation, lysis was performed in 
0.5  ml of P,  IPA modified buffer (1% NP40, 0.25% sodium de- 
oxycholate,  150  mM NaC1,  50  mM  Tris,  pH  7.5,  containing 
protease  inhibitors: 1 mM sodium orthovanadate, 1 mM PMSF, 
10  txg/ml aprotinin/leupeptin) for 30 min on ice.  Lysates were 
incubated with  15  I~I  rabbit  antisera  towards  mouse  PLC',/2 
(Santa Cruz Biotechnology, Santa Cruz, CA), for 1 h at 4~  fol- 
lowed by addition of protein A-Sepharose (Sigma Chemical Co.) 
for 1 h at 4~  Immune complexes were washed three times with 
lysis buffer containing protease  inhibitors followed by one wash 
in TN buffer (50 mM TrisC1, pH 7.5,  150 mM NaC1) containing 
protease  inhibitors.  Proteins were  separated  on  8%  polyacryl- 
amide  gels. Antiphosphotyrosine blots  were  performed  as  de- 
scribed above. Anti-PLC3,2 blots were visualized by stripping and 
probing blots with anti-PLCy2, followed by protein A-HRP. 
Determination of[Ca2+]i.  Cells at  5  ￿  106/n-tl in HBSS  (pH 
7.0)  received  the  acetoxymethyl  ester  of  indo-1  (Molecular 
Probes, Eugene, OR) to a final concentration of 1 ptM. After 30 
n'fin at 37~  an equal volume of HBSS containing 5% FCS (pH 
7.4) was added to cells for an additional 30 min at 37~  Cells 
were washed  once in HBSS/FCS (pH 7.4),  and resuspended  in 
either HBSS/FCS (pH 7.4) or HBSS  containing 0.5% BSA and 
10 mM Hepes (pH  7.3). Before  fluorescence  measurements,  ali- 
quots of 5 X 105 cells were preincubated at 37~  for 1-2 rain and 
were maintained at this temperature during measurement of the 
[Ca2+]i. Flow cytometric analysis of [Ca2+]i was carried out using 
a FACStar |  Plus  (Becton Dickinson) using an ion laser (Innova 
Enterprise;  Coherent, Santa Clara,  CA) optimized for UV argon 
ions, set for 355-nm excitation at a power setting of 50 mW. Dif- 
ferential analysis of intracellular mobilization of Ca  2+ vs extracel- 
lular influx was carried out by assessing the responsiveness of cells 
suspended  in Ca2+-free  HBSS  (buffered  with  1.8  mM EGTA) 
followed by repletion of the external Ca  2+ by addition of 4 mM 
CaC12. The response that occurs in Ca2+-free medium reflects in- 
tracellular release. 
Results and Discussion 
Cell Surface Phenotype of CD45-deficient Cells.  We  have 
previously reported that normal numbers orB cells arise in 
CD45-deficient mice (9). We examined several cell surface 
antigens which  characterize  the  progression of cells from 
the immature to the mature stage of B  cell differentiation. 
The  results  revealed  that  high  buoyant density splenic B 
cells obtained from CD45  -/-  mice differed significantly 
from their normal littermate controls (Fig. 1). The majority 
of splenic B  cells from normal mice were B220 +,  ~hi, boo, 
and CD23 +.  As  expected,  the  B  cells  obtained from  the 
CD45-/-  mice failed to express the B220 antigen. How- 
ever, we also found a significant decline in the frequency of 
the 8 hi,  I  xl~ population. In addition, there was a significant 
decline in B  cells expressing CD23  in CD45  -/-  mice. 
There was also a decline in the number of MHC class II  + 
cells.  Similar results were obtained for low buoyant density 
(1.079/1.066) B  cells,  whereas BM B  cells were phenotyp- 
ically normal (data not shown). These results raise the pos- 
sibility that B  cells in CD45-/-  mice may have  under- 
gone a developmental arrest characterized by the transition 
from the immature to mature B cell stage (13). 
T  Cells  Are  Not  Responsible  for  the  Lack  of Mature  B 
Cells.  CD45  -/-  mice lack functional T  cells  (9).  To 
determine if the B  cell phenotype was  due  the  lack of T 
cells we analyzed the B  cell phenotype in irradiated recipi- 
ents of bone marrow mixtures derived from CD45  -/- 
and normal mice. One of the most reliable markers for the 
CD45-/-  B cell phenotype is the level of 8 expression. In 
control studies in which the median ~ expression was corn- 
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Figure  1.  Flow  cytometric 
analysis of high buoyant density 
(1.085/1.079)  splenic  B  cells 
from  CD45  +/+  and  CD45  -/- 
mice.  The  percentage  of  cells 
within  the  boxed  regions  are 
based  on  the  total  number  of 
IgM + B  cells. Mean fluorescent 
values  determined  for  the  fol- 
lowing parameters  were  (+/+ 
vs -/-):  p~ (97 vs 135); B (209 
vs  78): CD23  (65  vs  23);  and 
MHC class I1 (223 vs 120). 
pared  in  age-matched  normal  and  CD45-/-  splenic  B 
cells  (five  separate  experiments,  each  with  at  least  two 
spleens/group)  the  ratio  of the median 8  intensity of nor- 
mal to  CD45  -/-  t  x+  B  cells was  1.72  -  0.6.  A  similar 
comparison  of two  normal  irradiated/reconstituted  mice, 
one  reconstituted with  +/+  bone marrow  and one with 
-/-  bone marrow resulted in a ~ ratio ofl.6  (+/+  : -/-). 
This result indicates that irradiation/reconstitution protocol 
does  not  alter  the  levels  of 8  subsequently obtained.  The 
median  ~  level was  then  determined  in  recipients  (either 
+ / +  or -/-)  reconstituted (for 9-11 wk) with a  1:1 mix- 
ture of normal and CD45-/-  B  cell-depleted bone mar- 
row. A  comparison was made between Ft+B220 +  cells (de- 
rived  from  the  normal  bone  marrow  and  representing 
"-"40%  of all  B  cells)  and  ~+B220-  cells  (derived  from 
CD45-/-  bone marrow and representing ~60%  of all B 
cells). The ratio of the median 8  intensity was found to be 
1.70  +  0.2.  This result demonstrates that even in the pres- 
ence of normal T  cells and B  cells, the CD45-/-  B  cells 
remain atypical. 
BCR  Cross-Linking  Fails  To  Induce B  Cell  Proliferation. 
Density  fractionation  of splenic  cells  on  Percoll  gradients 
revealed  that  the  CD45  -/-  cells  differed  considerably 
from  their  normal  counterparts.  In  four  separate  experi- 
ments,  using a  total  of at  least  10  individual spleens,  we 
found a  two-  to fourfold reduction in the number of high 
Figure 2.  lgpAnduced proliferation of splenic B cells.  Cells were cultured in either media alone (N.S.) or in the presence of 30 p~g/ml  of  purified anti-p~, 
(B76), 30 p~g/ml ofpolyclonal goat anti-mouse Igp~, or LPS (20 p~g/ml). Incorporation  of [3H]thymidine was determined at 24, 48, or 72 h. All assays 
were performed in tfiphcate. 
331  Benatar et al.  Brief Definitive Report buoyant  density  (>1.079)  B  cells.  In  the  same  spleens, 
however, we found a two- to fivefold increase in the num- 
ber of low buoyant density (1.079-1.066)  B  cells. Experi- 
ments  using  either  monoclonal  anti-t*  or  polyclonal  re- 
agents, revealed that neither the low nor the high buoyant 
density B  cells incorporate [3H]TdR upon cross-linking of 
Iglx (Fig. 2).  It has been reported that immature cells fail to 
proliferate upon  anti-Ig cross-linking (14).  In  this  respect 
they  are  similar to  the  CD45  -/-  B  cells and  might  be 
used to support the conclusion that the B cells in CD45  -/- 
mice  are  developmentally  arrested.  Note,  however,  that 
immature  cells  express  CD45  on  their  surfaces,  albeit  at 
lower levels (15). Thus the failure of immature cells to pro- 
liferate cannot be based on exactly the same parameters as 
the failure of CD45  -/-  mice to proliferate. 
Tyrosine Phosphorytation of mb-1  Occurs in Response  to Ig-t  z 
Cross-Linking.  It has been reported that the  Ig-associated 
protein, Igcx (mb-1), is hyperphosphorylated on tyrosine in 
a  B  cell line  deficient  in  CD45  expression  (1).  Further- 
more,  Igor  was  found  to  be  hyperphosphorylated  when 
CD45 was cross-linked on resting splenic B  cells (2). These 
experiments  suggested  that  CD45  may  play a  role  in  the 
maintenance  of the basal level of tyrosine phosphorylation 
oflgci. In contrast to these reports, Igor was not hyperphos- 
phorylated in B  ceils from CD45-/-  mice (Fig. 3). Upon 
Igbt cross-linking, Ige~ is inducibly phosphorylated on  ty- 
rosine  in  both  CD45+/+  and  CD45-/-  B  cells.  One 
explanation is that the population of B  cells found in CD45 
-/-  mice may have undergone strong selection for alter- 
native pathways which  have replaced the  need for CD45. 
According  to  this  hypothesis,  B  cells  from  normal  mice, 
having  the  luxury  of using  CD45  all their lives, may still 
depend  on  CD45  for  the  observed  effects.  Alternatively, 
the  CD45-regulated Igcl phosphorylation found by others 
may be unique to either the cell line used or to the method 
of manipulation of the  splenic B  cells in  the  sequestration 
studies. 
Anti-Ig-Induced  PLCT2  Activation  in  CD45-/-  B  Cells. 
Another  important  signaling  event  that  occurs  upon  Ig 
cross-linking is the tyrosine phosphorylation and activation 
of PLC~/2  (16-18). Results demonstrate that in response to 
Iglx cross-linking, a band of 140-150 kD, corresponding to 
PLCy2,  is  inducibly phosphorylated  in  both  CD45+/+ 
and  CD45-/-  B  cells (Fig. 4).  This  suggested that upon 
Ig cross-linking, CD45 is not required for the induction of 
tyrosine phosphorylation of PLC~/2 in B  cells. 
Mobilization  of Intracellular  Calcium  Is  Normal  but  Influx 
from  Extracellular Stores Is Abrogated in  CD45-deficient  B  Cells. 
We  examined  Ca  2+  mobilization in  response  to  anti-Igp~ 
cross-linking in high buoyant density splenic B  cells. Treat- 
ment with anti-tx resulted in an increase in intracellular cal- 
cium concentration in both normal and CD45-/-  B  cells 
(Fig.  5  A).  However,  while  the  amplitude of the  calcium 
mobilization in  CD45-/-  B  cells was similar to  that ob- 
served in  normal B  cells, Ca  2+  levels returned  to  baseline 
values more rapidly in the CD45  -/-  B  cells. This result 
suggested that CD45  -/-  cells may be unable to  use ex- 
tracellular stores of Ca  2+. This was directly tested by stimu- 
lating cells in  the  absence of extracellular Ca  2+.  As shown 
in Fig. 5  B  in the absence of extracellular Ca  2+,  both nor- 
mal and CD45  -/-  B  ceils responded to anti-Iglx with a 
rapid and  short-lived increase in  [Ca2+]i  .  The  addition of 
extracellular Ca  2+ to normal cells (arrow b) resulted in a sec- 
ond wave  of increased  [Ca2+]i reflecting the  use  of extra- 
cellular Ca  2+. In contrast, the addition ofextracellular Ca  2+ 
does not affect [Ca2+]i levels in  CD45-/-  B  cells. Previ- 
ous reports failed to reach a consensus regarding the role of 
CD45  in mobilization of Ca  2+.  The J558LIxm3  plasmacy- 
Figure 3.  Induction oftyrosine phosphorylation of Ig-ci. High buoyant 
density splenic B cells from CD45 +/+ and CD45 -/- mice stimulated for 
various time periods at 37~  with 30 p~g/ml  of anti-bt, B76. Igc~  was im- 
munoprecipitated with anti-Igct followed by separation of proteins on 
10% SDS-PAGE. (A) Antiphosphotyrosine blot of immunoprecipitated 
Ige~. (B)  Blots were  stripped and reprobed with  anti-Igo~  followed by 
anti-rabbit  HRP.  The migration position of molecular weight markers 
are indicated on the left. The position of lgcl is indicated by the arrow on 
the right. 
Figure  4.  Induction  of tyrosine phosphorylation of PLCg2. Whole 
splenic B cells were stimulated using goat anti-mouse IgM. (A) Antiphos- 
photyrosine blot of immunoprecipitated PLC~/2. (B) Blots were stripped 
and reprobed with anti-PLC"/2 followed by protein A-HRP. The arrow 
on the right represents the position of PLC~/2. 
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Figure 5.  Calcium mobilization in response to Igl~ cross- 
linking.  High  buoyant density splenic B  cells were loaded 
with indo-1, and stimulated with anti%t, B76  (40 btg/ml) 
(A, arrow  a), or B76 (40 gtg/ml) +  EGTA 1.8 mM (B, arrow 
a) followed 5 rain later by addition of 4 mM CaC12 (B, arrow 
b). lntracellular calcium increases were measured as the ratio 
of fluorescence of calcium-bound indo-1/calcium-free  indo- 
1 (4(15:530 nm) by flow cytometry. 
toma requires CD45 for Ca  2+ mobilization (1). In contrast, 
the  immature  cell line WEHI  231,  has  a  slightly  delayed 
but strong Ca  2+ mobilization response (8). Human tonsillar 
B  cells  have  reduced  anti-Ig-mediated Ca  2+  mobilization 
after  pretreatment  with  anti-CD45  antibodies  (6).  These 
reports  provided no indication that intracellular and extra- 
cellular sources of Ca  2+ may be subject to different regula- 
tory mechanisms. Our observation that the mobilization of 
intracellular stores  of Ca  2+  is  CD45  independent, but that 
subsequent  influx  of  Ca  2+  from  extracellular  sources  is 
CD45  dependent, reveals a previously unrecognized regu- 
latory event in B  cell activation. The absence of this event 
in CD45  -/-  mice may arrest B  cells at a stage of devel- 
opment  which  normally  would  be  characterized  by  the 
transition from the immature to mature splenic B  cell (13). 
This raises the possibility that such events may be regulated 
by the nature of external stimuli received by cells undergo- 
ing this transition. 
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